美国四家医疗系统粪便筛查结直肠癌的纵向依从性研究
这项回顾性队列研究随访了4家医疗系统中50至65岁、2010至2011年初始粪便免疫化学检测或愈创木脂粪便隐血试验阴性后符合重复筛查条件的成年人,最长10年。在492812人中,54%为持续重复筛查者,30%为不一致重复者,16%从未重复。医疗系统是持续筛查的最强预测因素,且持续筛查与更早的癌症分期相关。
要点
- 约半数(54%)初始粪便筛查阴性者能持续重复筛查,16%从未重复。
- 医疗系统是持续粪便筛查的最强预测因素,各中心差异大。
- 持续筛查者诊断时早期癌比例更高(56% vs 49%不一致和44%从未重复者)。
核心结论
- 初始年度粪便筛查阴性的患者中约54%持续重复筛查,16%从未重复。
- 患者所在医疗系统与持续粪便筛查关联最强,依从性越高诊断时癌症分期越早。
研究设计与样本
- 回顾性队列研究,随访4家美国医疗系统中50至65岁、2010至2011年初始粪便免疫化学检测或愈创木脂粪便隐血试验阴性后符合重复筛查条件的成年人,最长10年。
主要发现
- 共纳入492812人,54%为持续重复筛查者(≥75%轮次完成),30%为不一致重复者(<75%),16%为从未重复者。
- 从未重复者比例随随访时间延长而下降,不一致重复者比例上升,持续重复者比例基本稳定。
- 持续重复筛查与较年长、男性、非西班牙裔白人、较低合并症、体重指数<25 kg/m2、公共保险、既往粪便筛查及过去一年有初级保健就诊相关。
- 晚期结直肠癌在从未重复者中更常见(19% vs 不一致者12%和持续者12%)。
- 早期癌在持续重复者中更常见(56% vs 不一致者49%和从未重复者44%)。
临床怎么用
- 临床应关注粪便筛查的纵向重复依从性,而不仅是一次筛查完成率。
- 医疗系统层面因素影响持续筛查,可针对系统差异优化随访提醒。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Longitudinal adherence with annual stool-based screening for colorectal cancer is guideline-recommended. This paper assessed patterns and predictors of repeat stool-based screening over time and associated outcomes. METHODS: This retrospective cohort study followed adults aged 50 to 65 years in 4 health systems eligible for repeat screening following a negative index fecal immunochemical test or guaiac fecal occult blood test in 2010 to 2011 for up to 10 years. Repeat stool-based testing patterns were categorized as: consistent (≥75% of rounds completed, inconsistent [<75%], and never repeaters. Multivariable predictors of consistent testing were analyzed, as well as associations between screening consistency and cancer stage at diagnosis. RESULTS: Among 492,812 individuals, 54% were consistent repeaters, 30% inconsistent repeaters, and 16% never-repeaters. The proportion of never-repeaters declined with more follow-up time, whereas inconsistent repeating increased. Consistent repeating remained fairly constant. Health system was the strongest predictor of consistent screening, with wide variation by site. Consistent repeating was also associated with older age, male sex, being non-Hispanic White, lower comorbidity, body mass index <25 kg/m2, public insurance, prior stool-based testing, and a primary care provider visit in the past year. Advanced stage colorectal cancer was more frequent among never-repeaters (19% vs 12% for inconsistent and 12% consistent repeaters). Early-stage cancer was more common among consistent repeaters (56% vs 49% inconsistent and 44% never-repeaters). CONCLUSIONS: Among patients initially screened with an annual stool-based test, about one-half (54%) consistently repeated it, and 16% never repeated during available follow-up. The health system where the patient was cared for was most strongly associated with consistent stool-based testing, and higher adherence was associated with earlier cancer stage at diagnosis.
引用
- Halm EA, Nair R, Skinner CS, et al. Longitudinal Adherence With Stool-Based Testing for Colorectal Cancer Screening in Four United States Health Systems. Clin Gastroenterol Hepatol. 2026. PMID: 42320550. doi:10.1016/j.cgh.2026.06.019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。